本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioVie Inc

1.21
+0.348040.37%
盘后1.210.00000.00%16:08 EDT
成交量:804.26万
成交额:947.37万
市值:2,232.69万
市盈率:-0.39
高:1.31
开:0.9060
低:0.8800
收:0.8620
数据加载中...
2020/09/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/07

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/06

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/07/15

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/22

重要事件披露

8-K - Current report
2020/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/11

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/02/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/11/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2019/11/19

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/11/15

重要事件披露

8-K - Current report
2019/11/07

SEC问询函

CORRESP [Cover] - Correspondence
2019/11/07

SEC问询函

CORRESP [Cover] - Correspondence
2019/11/05

SEC问询函

CORRESP [Cover] - Correspondence
2019/11/05

SEC问询函

CORRESP [Cover] - Correspondence
2019/11/01

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2019/10/09

重要事件披露

8-K - Current report
2019/10/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933